<div id="readability-page-1">The Trump administration on Friday proposed two new programs aimed at saving Medicare billions of dollars on seniors' drugs by pegging what the government pays to prices in other developed countries. Why it matters: While President Trump's deals with drugmakers have focused primarily on getting Medicaid and direct-to-consumer drug prices in line with peer countries, the new efforts focus on Medicare. The notices for the pilot programs came hours...</div>

AIMID

<p>The Trump administration proposed two new programs to reduce Medicare drug costs by aligning them with prices in other developed countries, aiming to save billions. This initiative shifts focus from Medicaid and direct-to-consumer prices to Medicare, marking a significant policy move in healthcare pricing.</p>

Trump admin payment tests aim to lower Medicare drug prices